Catalent, Inc. (CTLT) stock remained unchanged at $63.48 a share on NYSE. The stock opened at $63.49, fluctuating between $63.44 to $63.50 during the session.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
Employees | 17000 |
Beta | 1.16 |
Sales or Revenue | $4.38B |
5Y Sales Change% | 0.258% |
Fiscal Year Ends | June |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Catalent, Inc. (NYSE: CTLT) stock price is $63.48 in the last trading session. During the trading session, CTLT stock reached the peak price of $63.50 while $63.44 was the lowest point it dropped to. The percentage change in CTLT stock occurred in the recent session was 0% while the dollar amount for the price change in CTLT stock was -.
The NYSE listed CTLT is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Catalent, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Paul Surdez
Vice President of Investor Relations
Mr. John R. Chiminski
Executive Chair of the Board
Dr. Aristippos Gennadios Ph.D.
Group Pres of Pharma & Consumer Health Segment
Mr. Joseph A. Ferraro J.D.
Senior Vice President, Gen. Counsel, Chief Compliance Officer & Sec.
Mr. Alessandro Maselli
Pres, Chief Executive Officer & Director
Mr. Ricky Hopson
Pres and Division Head for Clinical Devel. & Supply
Mr. Steven L. Fasman Esq.
Executive Vice President, Corporation Sec. & Chief Admin. Officer
Mr. Matti M. Masanovich
Senior Vice President & Chief Financial Officer
Ms. Lisa Evoli
SVice President & Chief HR Officer
Mr. Thomas P. Castellano
Senior Vice President & Chief Financial Officer
Ms. Karen Murphy Santiago
Vice President & Chief Accounting Office
Mr. Julien Meissonnier
Vice President & Chief Scientific Officer
Mr. Charles Lickfold
Senior Vice President & Chief Information Officer
Mr. Michael J. Grippo
Senior Vice President of Strategy & Corporation Devel.
Mr. Ricardo Pravda
Senior Vice President & Chief HR Officer
CTLT's closing price is 50.75% higher than its 52-week low of $42.11 where as its distance from 52-week high of $63.50 is -0.03%.
Number of CTLT employees currently stands at 17,000.
Official Website of CTLT is: https://www.catalent.com
CTLT could be contacted at phone 732 537 6200 and can also be accessed through its website. CTLT operates from 14 Schoolhouse Road, Somerset, NJ 08873, United States.
CTLT stock volume for the day was 13.67M shares. The average number of CTLT shares traded daily for last 3 months was 2.27M.
The market value of CTLT currently stands at $11.52B with its latest stock price at $63.48 and 181.51M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com